Christopher B Ehrlich E Ffector Therapeutics, Inc. (EFTR) insider trading activity

Christopher B Ehrlich is of eFFECTOR Therapeutics, Inc.. Currently has a direct ownership of 35,213 shares of EFTR, which is worth approximately $0. The most recent transaction as insider was on Oct 04, 2022, when has been sold 346 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.2K

0% 3M change

0% 12M change

Total Value Held $0

Christopher B Ehrlich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 04 2022	BUY Open market or private purchase	$197 $0.57 p/Share	346 Added 0.97%	35,213 Common Stock
Sep 26 2022	BUY Open market or private purchase	$10,377 $0.55 p/Share	18,867 Added 35.11%	34,867 Common Stock
Feb 18 2022	BUY Open market or private purchase	$4,300 $4.3 p/Share	1,000 Added 5.88%	16,000 Common Stock
Feb 14 2022	BUY Open market or private purchase	$8,900 $4.45 p/Share	2,000 Added 11.76%	15,000 Common Stock
Feb 09 2022	BUY Open market or private purchase	$4,750 $4.75 p/Share	1,000 Added 7.14%	13,000 Common Stock
Feb 08 2022	BUY Open market or private purchase	$4,920 $4.92 p/Share	1,000 Added 7.69%	12,000 Common Stock
Feb 04 2022	BUY Open market or private purchase	$5,000 $5.0 p/Share	1,000 Added 8.33%	11,000 Common Stock
Feb 03 2022	BUY Open market or private purchase	$25,750 $5.15 p/Share	5,000 Added 33.33%	10,000 Common Stock
Jan 27 2022	BUY Open market or private purchase	$26,500 $5.3 p/Share	5,000 Added 50.0%	5,000 Common Stock

Also insider at

PBAXU

PHOENIX BIOTECH ACQUISITION CORP. Financial Services

Interim Chairman and CEO

CBE